EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HOXD9 Enhances the Release of HMGB1 and Boosts Glycolysis in Glioblastoma under Hypoxic Conditions, Leading to Tumor Growth by Activating the Transcription of PFKFB3

Guangzhi Xu, Jingchi Sun, Lizhou Wei, Xicai Yi, Fuxin Han, Weiping Liu

Frontiers in Bioscience-Landmark · 2024

DOI: 10.31083/j.fbl2910341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Guangzhi Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xijing Hospital, Air Force Medical University of PLA, 710000 Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Phosphofructokinase-2, HMGB1 Protein, Homeodomain Proteins, Glycolysis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Instrument Project of National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma (GBM) is an aggressive primary brain tumor. The HOX gene family has been implicated in the pathogenesis of different types of tumors. This research aimed to examine the impact of homeobox D9 (HOXD9) in GBM under hypoxic conditions, as well as to elucidate its underlying molecular mechanisms.

Methods

The study assessed the differential expression of nine HOXD genes in GBM using the Mann-Whitney U test and identified genes with high correlation with the cancer genome atlas (TCGA)-GBM dataset using receiver operating characteristic (ROC) curves. Prognostic genes of GBM patients were identified through a combination of prognostic Kaplan-Meier (KM) curve and Cox analysis. In vitro experiments were conducted using U87-MG and U251-MG cells, and an animal GBM model was constructed. The study also measured the secretion level of high mobility group box 1 (HMGB1) using enzyme-linked immunosorbent assay (ELISA). Glucose uptake and lactate production levels in cells and tissues were analyzed using kits. The expressions of HOXD9 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) were detected by immunofluorescence, and chromatin immunoprecipitation (ChIP) validated their relationship.

Results

HOXD9 was identified as the target gene, showing a significant correlation between HOXD9 expression and prognostic clinical outcomes. Overexpression of HMGB1 enhanced cell proliferation, migration, and the expression levels of HOXD9 and PFKFB3 and promoted HMGB1 secretion, glucose uptake, and lactate generation. HOXD9 bound to the PFKFB3 promoter region in U87-MG and U251-MG cells. Furthermore, PFKFB3 overexpression partially counteracted the suppressive effects of HOXD9 silencing on tumor formation.

Conclusion

HOXD9 promoted hypoxia-induced HMGB1 secretion and glycolysis in GBM through the transcriptional activation of PFKFB3, which in turn promoted tumorigenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphofructokinase-2HMGB1 ProteinHomeodomain ProteinsGlycolysisGlioblastomaBrain NeoplasmsGene Expression Regulation, NeoplasticHumansCell Line, TumorAnimalsCell ProliferationMaleMiceFemaleMice, NudePrognosisTumor HypoxiaMiddle AgedNeoplasm Proteins

Stichwörter der Autor:innen

HMGB1HOXD9/PFKFB3glioblastomaglycolysishypoxia induction

Substanzen

Phosphofructokinase-2HMGB1 ProteinHomeodomain ProteinsPFKFB3 protein, humanHOXD9 protein, humanHMGB1 protein, humanNeoplasm Proteins

Autor:innen und Institutionen

  • Department of Neurosurgery, Xijing Hospital, Air Force Medical University of PLA, 710000 Xi'an, Shaanxi, China.
  • Department of Medical Administration, The Third People's Hospital of Chengdu, 610014 Chengdu, Sichuan, China.
  • Department of Neurosurgery, Xi'an People's Hospital, 710000 Xi'an, Shaanxi, China.

Förderung

  • Major Instrument Project of National Natural Science Foundation of China

Zitieren

APA

Xu, G., Sun, J., Wei, L., Yi, X., Han, F., & Liu, W. (2024). HOXD9 Enhances the Release of HMGB1 and Boosts Glycolysis in Glioblastoma under Hypoxic Conditions, Leading to Tumor Growth by Activating the Transcription of PFKFB3. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2910341

Vancouver

Xu G, Sun J, Wei L, Yi X, Han F, Liu W. HOXD9 Enhances the Release of HMGB1 and Boosts Glycolysis in Glioblastoma under Hypoxic Conditions, Leading to Tumor Growth by Activating the Transcription of PFKFB3. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2910341

BibTeX
@article{Xu2024,
  author = {Xu, Guangzhi and Sun, Jingchi and Wei, Lizhou and Yi, Xicai and Han, Fuxin and Liu, Weiping},
  title = {HOXD9 Enhances the Release of HMGB1 and Boosts Glycolysis in Glioblastoma under Hypoxic Conditions, Leading to Tumor Growth by Activating the Transcription of PFKFB3},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  doi = {10.31083/j.fbl2910341}
}
Kostenlos starten →